Werewolf Therapeutics (HOWL) Non-Current Debt (2023 - 2025)

Werewolf Therapeutics (HOWL) has reported Non-Current Debt for 3 consecutive years, with $21.7 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Non-Current Debt fell 15.46% year-over-year to $21.7 million in Q3 2025; TTM through Sep 2025 was $21.7 million, a 15.46% decrease from a year earlier, with the FY2024 full-year figure at $26.1 million, down 20.09% from the prior year.
• Non-Current Debt was $21.7 million for Q3 2025 at Werewolf Therapeutics, down from $24.7 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $39.1 million in Q2 2023 and troughed at $21.7 million in Q3 2025.
• A 3-year average of $29.6 million and a median of $26.6 million in 2025 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt tumbled 35.71% in 2024 and decreased 1.82% in 2025, its largest moves.
• Over 3 years, Non-Current Debt stood at $32.7 million in 2023, then dropped by 20.09% to $26.1 million in 2024, then retreated by 17.01% to $21.7 million in 2025.
• The last three Non-Current Debt figures came in at $21.7 million (Q3 2025), $24.7 million (Q2 2025), and $26.6 million (Q1 2025), per Business Quant data.